Bliss GVS Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹256.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.75 per cent from ₹218.25 crore. This corresponds to a year-on-year *(YoY) growth of 29.80 per cent.
Operating Profit
Operating Profit stands at ₹44.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 37.71 per cent from ₹32.27 crore. This corresponds to a year-on-year *(YoY) growth of 110.72 per cent.
PBDT
PBDT stands at ₹53.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.87 per cent from ₹49.25 crore. This corresponds to a year-on-year *(YoY) growth of 70.33 per cent.
Profit Before Tax
Profit Before Tax stands at ₹44.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.90 per cent from ₹40.90 crore. This corresponds to a year-on-year *(YoY) growth of 91.77 per cent.
Net Profit
Net Profit stands at ₹37.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 49.31 per cent from ₹24.78 crore. This represents a 122.22 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bliss GVS Pharma Ltd Earnings
- YOY
- QOQ
Bliss GVS Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bliss GVS Pharma Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bliss GVS Pharma Ltd Financial Reports
Bliss GVS Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bliss GVS Pharma | 4.15% | 4.12% | 24.38% | 103.75% | 206.04% | 242.76% |
| Senores Pharma. | 0.06% | 2.95% | 27.78% | 72.55% | 74.91% | 141.33% |
| Aarti Pharma | 2.04% | -0.58% | 12.95% | 1.89% | -7.00% | -22.87% |
| Innova Captab | -0.54% | 3.47% | 9.03% | 43.46% | 44.83% | 13.98% |
| Orchid Pharma | 4.44% | 9.51% | 23.24% | 87.41% | 45.02% | 44.97% |
| IOL Chemicals | 0.81% | 17.48% | 29.82% | 104.61% | 121.56% | 84.53% |
| Unichem Labs. | 13.93% | 37.61% | 48.22% | 91.93% | 56.60% | 8.84% |
Company Info
Company Information
Chairman & Independent Directo : Nandkumar Kashinath Chodankar
Independent Non Executive Women Director : Shilpa Bhatia
ED / MD / CEO / Promoter : Shibroor N Kamath
Independent Non Exe. Director : Vijayanarayanan Mahadevan
Independent Non Exe. Director : Deepak Rameshchandra Shah
Company Secretary : Aditi Bhatt